Press Release Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients Sagimet Biosciences Inc. · Aug 13
Press Release LENSAR® Reports Second Quarter 2026 Results and Provides Business Update LENSAR, Inc. · Aug 13
Press Release ProQR Announces Second Quarter 2026 Operating and Financial Results ProQR Therapeutics N.V. · Aug 13
Press Release Rocket Lab Corporation Announces Dollar-for-Dollar Replacement At-The-Market Equity Program Rocket Lab Corporation · Aug 13
Press Release Aebi Schmidt Group Reports 22% Increase in Adjusted EBITDA, 16% Growth in Order Intake and 9% Increase in Net Sales, Reflecting Strong Order Momentum and Over-Proportional Profitability Improvement Aebi Schmidt Group / Aebi Schmidt Holding AG · Aug 13
Press Release NACCE Short Tracks Career Paths at NASCAR National Association for Community College Entrepreneurship · Aug 13
Press Release E-STORAGE’s KuBank 3.0 for C&I Applications Successfully Passes Large-Scale Fire Testing Canadian Solar Inc. · Aug 13
Press Release Ardagh Holdings S.A. Files an Amendment to Schedule 13D with the U.S. Securities and Exchange Commission Regarding Ardagh Metal Packaging S.A. Ardagh Metal Packaging S.A. · Aug 13
Press Release Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona Accro Bioscience Inc. · Aug 13
Press Release Ardagh Holdings S.A. Files Amendment to Schedule 13D with the U.S. Securities and Exchange Commission Regarding Ardagh Metal Packaging S.A. Ardagh Group S.A. · Aug 13